Antibody-Mediated Protection through Cross-Reactivity Introduces a Fungal Heresy into Immunological Dogma
- 1 November 2007
- journal article
- review article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 75 (11), 5074-5078
- https://doi.org/10.1128/iai.01001-07
Abstract
No abstract availableThis publication has 66 references indexed in Scilit:
- An Anti-β-Glucan Monoclonal Antibody Inhibits Growth and Capsule Formation of Cryptococcus neoformans In Vitro and Exerts Therapeutic, Anticryptococcal Activity In VivoInfection and Immunity, 2007
- A Comparison of the Pulmonary Inflammatory Potential of Different Components of Yeast Cell Wall*Journal of Toxicology and Environmental Health, Part A, 2007
- Natural Antibody and Complement Mediate Neutralization of Influenza Virus in the Absence of Prior ImmunityJournal of Virology, 2007
- Vaccinations with Recombinant Variants of Aspergillus fumigatus Allergen Asp f 3 Protect Mice against Invasive AspergillosisInfection and Immunity, 2006
- A Fungicidal Monoclonal Antibody Protects against Murine Invasive CandidiasisInfection and Immunity, 2006
- Active Immunization against Pneumocystis carinii with a Recombinant P. carinii AntigenInfection and Immunity, 2006
- Specific Antibody Can Prevent Fungal Biofilm Formation and This Effect Correlates with Protective EfficacyInfection and Immunity, 2005
- Monoclonal Immunoglobulin G1 Directed againstAspergillus fumigatusCell Wall Glycoprotein Protects against Experimental Murine AspergillosisClinical and Vaccine Immunology, 2005
- Circulating β (1-3) Glucan and Immunoglobulin G Subclass Antibodies toCandida albicansCell Wall Antigens in Patients with Systemic CandidiasisClinical and Vaccine Immunology, 2004
- Human Antibodies against a Purified Glucosylceramide fromCryptococcus neoformansInhibit Cell Budding and Fungal GrowthInfection and Immunity, 2000